AU6415000A - Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay - Google Patents

Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay

Info

Publication number
AU6415000A
AU6415000A AU64150/00A AU6415000A AU6415000A AU 6415000 A AU6415000 A AU 6415000A AU 64150/00 A AU64150/00 A AU 64150/00A AU 6415000 A AU6415000 A AU 6415000A AU 6415000 A AU6415000 A AU 6415000A
Authority
AU
Australia
Prior art keywords
immunoassay
diagnosing
antibody composition
predicting cardiovascular
indicator peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64150/00A
Inventor
Gerhard Hawa
Wolfgang Woloszczuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomedica GmbH
Original Assignee
Biomedica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica GmbH filed Critical Biomedica GmbH
Publication of AU6415000A publication Critical patent/AU6415000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU64150/00A 1999-08-20 2000-08-17 Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay Abandoned AU6415000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT1444/99 1999-08-20
AT144499A AT407580B (en) 1999-08-20 1999-08-20 INDICATOR PEPTIDE FOR DIAGNOSIS AND / OR PREDICTION OF CARDIOVASCULAR AND / OR ENDOTHELIAL DISEASES, ANTIBODY COMPOSITION AND IMMUNOASSAY
PCT/AT2000/000224 WO2001014885A2 (en) 1999-08-20 2000-08-17 Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay

Publications (1)

Publication Number Publication Date
AU6415000A true AU6415000A (en) 2001-03-19

Family

ID=3514025

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64150/00A Abandoned AU6415000A (en) 1999-08-20 2000-08-17 Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay

Country Status (4)

Country Link
AT (1) AT407580B (en)
AU (1) AU6415000A (en)
DE (1) DE10082504B4 (en)
WO (1) WO2001014885A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
CA2414073A1 (en) 2001-05-04 2002-11-14 Gunars E. Valkirs Diagnostic markers of acute coronary syndromes and methods of use thereof
US7608406B2 (en) 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP2005522669A (en) 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド Diagnostic markers for stroke and brain injury and methods of use thereof
US20050069549A1 (en) 2002-01-14 2005-03-31 William Herman Targeted ligands
DK1644740T3 (en) * 2003-06-17 2011-02-21 Otago Innovation Ltd Assessment of skeletal growth using measurements of NT-CNP peptides
ES2311895T3 (en) * 2004-03-15 2009-02-16 F. Hoffmann-La Roche Ag THE USE OF BNP TYPE PEPTIDES AND ANF TYPE PEPTIDES TO ASSESS THE RISK OF PADDING A CARDIO-VASCULAR COMPLICATION AS A FREQUENCY OF OVERLOADING THE VOLUME.
EP2118665B1 (en) * 2007-03-12 2012-04-18 Biomedica Medizinprodukte GmbH & Co KG Diagnosis of septic complications
AT504943A1 (en) * 2007-03-12 2008-09-15 Biomedica Medizinprodukte Gmbh DIAGNOSIS OF SEPTIC COMPLICATIONS
EP2060920A1 (en) * 2007-11-19 2009-05-20 Biomedica Medizinprodukte GmbH & Co KG Diagnosis of septic complications
CN104937420B (en) * 2012-08-13 2018-07-03 奥塔哥创业有限公司 As vascular diseases and the NT-proCNP of the biomarker of complications of pregnancy
WO2017142745A1 (en) 2016-02-17 2017-08-24 The Curators Of The University Of Missouri Fabrication of multilayer nanograting structures
CN112710852B (en) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 GNP polypeptide detection kit and detection method

Also Published As

Publication number Publication date
WO2001014885A2 (en) 2001-03-01
AT407580B (en) 2001-04-25
ATA144499A (en) 2000-08-15
DE10082504B4 (en) 2009-05-07
DE10082504D2 (en) 2003-03-13
WO2001014885A3 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
AU2922497A (en) Detection probes, kits and assays
AU3367799A (en) Methodology for predicting and/or diagnosing disease
AU6415000A (en) Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay
AU9586798A (en) Analyte assaying device
AU3667399A (en) Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
IL147517A0 (en) Monoclonal antibodies and immunoassay utilizing the same
AU6618100A (en) Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
AU2735797A (en) Detection probes, kits and assays
AU7960600A (en) Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
GB0200425D0 (en) Methods and compositions fo assaying analytes
EP1130401A3 (en) Assays for measurement of type II collagen fragments in urine
AU2000264217A1 (en) Method for detecting serum and for determining the quality thereof, and corresponding devices
AU5449099A (en) Novel receptor protein and method for diagnosing inflammatory diseases by using the same
AU2547995A (en) Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
AU1055997A (en) Luminescent probes for protein detection
AU2001267922A1 (en) Method of assaying the function of fc fragment of antibody
AU3257399A (en) Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein
EP0959078A4 (en) Peptides, methods for assaying human pepsinogen i or human pepsin i, and assay kits
AU1657501A (en) Determining the functions and interactions of proteins by comparative analysis
ZA200100234B (en) Immunoassay testing kit and containers.
WO2000077518A3 (en) Methods and compositions for opsonophagocytic assays
AU8657998A (en) Diagnostic assays and kits for body mass and cardiovascular disorders
AU3511900A (en) Bovine pregnancy testing
AU5763100A (en) Non-destructive cell-based assay
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase